RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia
dc.contributor.author | Koschut, D | |
dc.contributor.author | Ray, D | |
dc.contributor.author | Li, Z | |
dc.contributor.author | Emanuela, G | |
dc.contributor.author | Groet, J | |
dc.contributor.author | Ivan, A | |
dc.contributor.author | Kham, SK-Y | |
dc.contributor.author | Chng, WJ | |
dc.contributor.author | Ariffin, H | |
dc.contributor.author | Weinstock, DM | |
dc.contributor.author | Yeoh, AE-J | |
dc.contributor.author | Basso, G | |
dc.contributor.author | Nizetic, D | |
dc.date.accessioned | 2020-11-17T16:49:51Z | |
dc.date.available | 2020-11-11 | |
dc.date.available | 2020-11-17T16:49:51Z | |
dc.identifier.issn | 0950-9232 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/68389 | |
dc.publisher | Springer Nature [academic journals on nature.com] | en_US |
dc.relation.ispartof | Oncogene | |
dc.title | RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia | en_US |
dc.type | Article | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Accepted | en_US |
dcterms.dateAccepted | 2020-11-11 | |
dcterms.rights | CC BY | |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |